Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Wyeth's Pristiq available in U.S. pharmacies for major depressive disorder

May 16, 2008

Orexo submits NDA to the FDA for Sublinox (OX-22) for short-term insomnia

May 16, 2008

Pfizers's ziprasidone under study in children and adolescents with bipolar I disorder

May 16, 2008

Valeant reports positive results from phase III RESTORE 2 trial of retigabine in epilepsy

May 16, 2008

Alseres announces 12-month interim data from phase I/IIa clinical trial of Cethrin in SCI

May 16, 2008

FDA approves Seroquel for maintenance treatment in bipolar disorder

May 15, 2008

FDA grants marketing approval to Novalar's dental anesthetic reversal agent OraVerse

May 15, 2008

DMXB-Anabaseine improves negative symptoms in phase II schizophrenia trial

May 15, 2008

FDA grants priority review of Gamunex as treatment for neurological disorder CIDP

May 14, 2008

Orion discontinues development of new COMT inhibitor for Parkinson's disease

May 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...